Table S1.
Expression of YOD1 and YAP in hepatocellular carcinoma patients
| Patient case number | Normal tissue | Tumor | ||
| YOD1 | YAP | YOD1 | YAP | |
| I | 1 | 1 | 1 | 3 |
| II | 1 | 1 | 1 | 1 |
| III | 1 | 0 | 2 | 1 |
| IV | 1 | 1 | 2 | 2 |
| V | 1 | 0 | 1 | 0 |
| VI | 1 | 1 | 2 | 1 |
| VII | 1 | 0 | 2 | 0 |
| VIII | 1 | 0 | 2 | 3 |
| IX | 1 | 0 | 3 | 2 |
| X | 1 | 0 | 2 | 2 |
| XI | 1 | 0 | 1 | 3 |
| XII | 1 | 1 | 2 | 3 |
| XIII | 1 | 0 | 1 | 2 |
| XIV | 1 | 0 | 3 | 3 |
| XV | 2 | 2 | 2 | 2 |
| XVI | 1 | 0 | 3 | 3 |
| XVII | 2 | 1 | 3 | 2 |
| XVIII | 2 | 0 | 2 | 3 |
| XIX | 1 | 0 | 2 | 0 |
| XX | 1 | 0 | 1 | 2 |
The expression levels of YOD1 and YAP were examined in 20 hepatocellular carcinoma patients. Protein levels were examined in tumors and normal tissues contiguous to tumors. The number stands for the intensity of staining: 0, negative; 1, weak; 2, moderate; 3, strong.